Effect of tumour size on the in vivo growth inhibition of human colon carcinoma cells (HT-29) by colon mitosis inhibitor

In Vivo

Volumn 15, Issue 5, 2001, Pages 397-401

  Paulsen, J E ^a   Elgjo, K ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Colon carcinoma; Colon mitosis inhibitor; Growth inhibition; HT 29 cells

Indexed keywords

CYTOTOXIC AGENT; EFLORNITHINE; RETINOIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER SIZE; CELL STRAIN HT29; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MITOSIS; MOUSE; MOUSE STRAIN; NONHUMAN; RETROSPECTIVE STUDY; TREATMENT FAILURE;

EID: 0034761081     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Growth-inhibiting N-substituted endogenous peptides
2. Purifi-cation and characterization of a mitosis inhibiting tripeptide from mouse intestinal extracts
3. An endogenous colon mitosis inhibitor reduces proliferation of colon carcinoma cells (HT-29) in serum-restricted medium
4. The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into thymic mice
5. The relationship between tumor size and chemosensitivity of murine bladder cancer
6. Differences in chemoprevention between subcutaneous and pulmonary tumours
7. In vivo growth inhibition of human colon carcinoma cells (HT-29) by all-trans-retinoic acid, difluoromethylornithine, and colon mitosis inhibitor, individually and in combination
8. Intratumoral vascular changes with increased size of a mammary adenocarcinoma: New method and results
9. Quantitative techniques for study of the anatomy and function of small blood vessels in tumors
10. Restoration by polyethylene glycol of characteristics of intestinal differentiation in subpopulations of the human colonic adenocarcinoma cell line HT29
11. A comparison of the chemosensitivity of a primary tumor and its metastases using a human tumor xenograft